COMMUNIQUÉS West-GlobeNewswire

Receipt of Nasdaq Delisting Determination - Plans to Appeal

30/08/2024 - 22:30

August 30, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Receipt of Nasdaq Delisting Determination Plans to Appeal Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage [...]

Rakovina Therapeutics Announces 2024 Q2 Financial Results and Provides Corporate Update

30/08/2024 - 22:10

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company [...]

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

30/08/2024 - 22:05

DURHAM, N.C., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on August 20, 2024, the Compensation Committee of Chimerix’s Board of Directors granted an inducement award to a new employee [...]

IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma

30/08/2024 - 22:05

- Based on a per-protocol interim analysis of safety and efficacy data, the Independent Data Monitoring Committee (IDMC) recommended that the trial continue without modifications - No new safety signals observed at [...]

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

30/08/2024 - 22:00

Company announcement – No. 43 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, August [...]

Fagron’s share buy-back program: Weekly update

30/08/2024 - 18:34

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 30 August 2024 – 6PM CET Fagron’s share buy-back program: Weekly update In the period from 26 August 2024 through 30 August 2024, Fagron purchased 37 [...]

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

30/08/2024 - 17:07

Please see enclosed pdf. Attachment 30082024_trading_in_shares_PRM

Total number of shares and voting rights in Zealand Pharma on August 30, 2024

30/08/2024 - 17:00

Company announcement – No. 42 / 2024 Total number of shares and voting rights in Zealand Pharma on August 30, 2024 Copenhagen, Denmark, August 30, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 [...]

BridgeBio Shares Data on Serum TTR Increase When Switching Participants from Placebo and Tafamidis to Acoramidis in ATTRibute-CM and its Open-Label Extension

30/08/2024 - 16:50

- In participants who switched from tafamidis and placebo in the ATTRibute-CM study to acoramidis in its open-label extension (OLE), there was a mean of 3.0mg/dL increase in serum transthyretin (TTR) at Month 1 of the [...]

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

30/08/2024 - 16:02

Please see enclosed pdf. Attachment 30082024_trading_in_shares_ARA

Children’s Hospital at London Health Sciences Centre and Shriners Hospitals for Children Canada announce groundbreaking affiliation agreement

30/08/2024 - 16:00

In a Canadian first, the two major paediatric hospitals join forces to offer orthopaedic care closer to home and develop innovative teaching and research initiatives LONDON, Ontario, Aug. 30, 2024 (GLOBE NEWSWIRE) -- [...]

L’Hôpital pour enfants du Centre des sciences de la santé de London et les Hôpitaux Shriners pour enfants Canada annoncent une importante entente d'affiliation

30/08/2024 - 16:00

Une première en son genre au Canada, deux principaux hôpitaux pédiatriques unissent leurs forces pour offrir aux patients des soins orthopédiques spécialisé plus près du domicile et développer des initiatives innovantes [...]

Nymox Announces Filing of Annual Report

30/08/2024 - 15:30

IRVINE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (“Nymox”) (OTC Markets NYMXF) is pleased to report that it filed its Annual Report with the Security and Exchange Commission (SEC) on [...]

Scilex Holding Company to Present Oral, Poster Presentations and Symposia on ZTlido (lidocaine topical system) at the 2024 Annual PAINWeek Conference in Las Vegas, NV on September 3-5, 2024

30/08/2024 - 15:00

PALO ALTO, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]

SS Innovations Issues Update on Status of Audit Process and Trading Market for Common Stock

30/08/2024 - 14:55

FORT LAUDERDALE, Fla., Aug. 30, 2024 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making [...]

Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness

30/08/2024 - 14:16

For the second year, Emergent is teaming up with pro football legend, Emmitt Smith, to educate communities on opioid risks and how to be prepared with NARCAN ® Nasal Spray In recognition of International Overdose [...]

CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

30/08/2024 - 14:00

IRVINE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing [...]

NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in September

30/08/2024 - 14:00

NAARDEN, The Netherlands and MIAMI, Aug. 30, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral [...]

Disc Medicine to Participate in Upcoming Investor Conferences

30/08/2024 - 14:00

WATERTOWN, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]